Abstract: Endovascular repair of abdominal aortic aneurysms have been performed successfully since 1991. However, 20% to 50% of these patients may develop an endoleak or continued aneurysmal sac expansion or perfusion despite stent graft coverage. Current recommendations suggest lifelong surveillance with computed tomographic angiography (CTA) at least 1 month after intervention and yearly after that. In select patients with a stable aneurysm sac on computed tomography performed 1 year after treatment, future screening could be performed with ultrasonography. However, color Doppler ultrasound can fail to detect as many as 31% of endoleaks. Contrast-enhanced ultrasound (CEUS) provides an alternative approach to excluded aneurysm sac follow-up imaging. The Society for Vascular Surgery notes a need for further research on the role of CEUS in endovascular aortic repair surveillance. The European Federation of Societies for Ultrasound in Medicine and Biology suggests that early results are promising. Metaanalyses report pooled sensitivities and specificities of CEUS compared with CTA for the detection of endoleak between 89% and 98% and 86% and 88%, respectively. Owing to the dynamic flow information it provides, CEUS may actually be more sensitive than CTA at detection and characterization in select circumstances. Challenges with adoption, patient selection, and operator dependency remain, but current and future research suggests a role for CEUS in endoleak surveillance.
technique accounts for more than 56% of all abdominal aortic aneurysm repairs in the United States. 2 In the appropriately selected patient, an endovascular approach significantly reduces perioperative morbidity and mortality. 3 However, between 20% and 50 % of these patients treated with EVAR may develop endoleaks, with some requiring reoperation. 4 Endoleak is defined as continued aneurysm sac pressurization or expansion despite being covered by an endograft. 4 Endoleaks are classified by the presumed source of continued sac pressurization (Fig. 1 ). Type I endoleaks are seal failures between the graft and the native aorta at the proximal or distal ends. 4 Type II endoleaks occur when a patent arterial vessel retrograde fills the aneurysm sac. 4 Type III endoleaks occur through the body of the graft via gaps between components or actual tears in the graft. 4 Type IV endoleaks occur with extravasation of blood products through the graft wall into the sac as a function of the implant fabric porosity. 4 Finally, there is a subset of patients for whom aneurysm sac expansion occurs but no perfusion source is identified. These have been labeled type V endoleaks and may be due to a phenomenon called "endotension" in which increased sac pressure is experienced despite no identifiable flow. 4 Because endoleaks are often asymptomatic and early recognition may allow for elective minimally invasive intervention, the Society of Vascular Surgery (SVS) recommends lifelong surveillance. 5 The criterion standard recommended by the SVS is computed tomographic angiography (CTA) with 3-dimensional reconstruction at 1 month after operation and yearly after that. 5 If an abnormality is noted at the initial postoperative imaging, a second scan is recommended at 6 months to document stability. 5 The SVS concedes that there are concerns with cost, nephrotoxicity, and radiation exposure with lifelong computed tomographic (CT) imaging and suggests that color Doppler ultrasonography might be substituted in place of CTA if no abnormalities are found in the first year and in patients with contraindications to CTA. 5 However, color Doppler ultrasound is less sensitive than CTA, failing to detect as many as 31% of endoleaks. [5] [6] [7] Instead, in 2009, the SVS practice guidelines noted a need for research on defining the role of contrast-enhanced ultrasound (CEUS) in postoperative surveillance. 5 Subsequent meta-analyses and systematic reviews have been performed showing a comparable diagnostic accuracy to CTA in the detection of endoleaks. [8] [9] [10] [11] In their 2011 practice guidelines update on nonhepatic applications of CEUS, the European Federation of Societies for Ultrasound in Medicine and Biology suggests that early results are promising and that CEUS may actually be particularly more suited for characterization of endoleaks than CTA. 12 In this narrative review, we highlight the salient body of literature available on the role of CEUS in endoleak identification and categorization.
TECHNICAL CONSIDERATIONS OF CEUS
Ultrasound contrast agents function by their inherent nonlinear scatter of transmit ultrasound frequencies ( f 0 ) into subharmonic (1/2* f 0 ) and superharmonic (n*f 0 ) signals. 13 This is unlike the generally linear scatter of surrounding tissue. 13 Using pulse inversion techniques, unenhanced tissue suppression may be achieved-allowing for greater contrast-to-tissue signal ratio. 13 Multiple agents are available (Table 1) , differentiated by their gas core and outer shell.
14 Early agents ("first-generation") used an air gas core.
14 However, these first-generation contrast agents were easily destroyed (even at low mechanical indices) and short lived because of their high blood solubility, limiting use to intermittent pulse imaging.
14 Newer agents ("secondgeneration") are characterized by a high-density, low-solubility gas core that allows for real-time imaging and quantitative analysis.
14 Of note, although these agents are not currently approved by the Food and Drug Administration for endoleak surveillance, approved indications include echocardiography, the evaluation of focal hepatic masses, and the assessment of ureterovesical reflux (the latter 2 with regard to only Lumason at this time).
The CEUS holds several potential advantages over CTA. There is no concern for nephrotoxicity or radiation exposure. 13 Furthermore, CTA may have difficulty in characterizing endoleaks obscured by metallic streak artifact (from the endograft) or of particularly low flow. 15, 16 In addition, ultrasonography is less expensive. 8 However, several limitations exist. The CEUS requires appropriate training and additional expertise in technical application and interpretation. 8 Because of the aorta's midline retroperitoneal location, interposed bowel gas can make obtaining an adequate window difficult. 8 Abdominal wall hernias, hernia mesh, significant ascites, and an obese body habitus can further worsen visualization. 8 Consequently, we recommend a standardized approach to scanning postoperative EVAR patients when performing CEUS ( Table 2) .
APPROACH TO CEUS IN POST-EVAR SURVEILLANCE
The patient should be advised to avoid taking anything by mouth the morning of the study to decrease bowel gas and meteorite artifact. Upon arrival, the patient should be positioned supine and a straight, antecubital intravenous (22 gauge or larger) should be established.
Before contrast infusion, the aortic endograft is evaluated in the standard fashion. A low-frequency (1-5 MHz) curvilinear array probe is oriented transversely beginning in the epigastrium and moving caudally through the iliac bifurcation to both inguinal ligaments. B-mode should be used to measure maximal aneurysmal sac and iliac diameters. Stent continuity should be documented. In addition, color Doppler and spectral Doppler are used to assess both distal limb signal waveforms, evaluate for residual sac flow, and interrogate flow through a patent inferior mesenteric artery and paired lumbar arteries. Velocities through the stent graft, iliac limbs, renal vessels, and mesenteric vessels should be recorded. The examination should be repeated in the sagittal orientation. Of note, the insonation angle should be less than 60 degrees and gain set as high as possible without creating significant artifact to facilitate detection of smaller lowflow vessels. Next, the contrast-enhanced portion of the exam is performed (Fig. 2) . Although a variety of protocols exist, we use a bolus dose of 0.2 mL Definity (Lantheus, North Billerica, MA) or 1.5 mL of Lumason (Bracco Diagnostics, Princeton, NJ) followed by a 10-mL saline flush for enhancement. Dualscreen format is used with B-mode display on the left and contrast display on the right to guide anatomic landmarks. The focal zone should be placed just beyond the aorta. The need for increased mechanical index for adequate signal intensity at this focal distance should be balanced against increased bubble destruction. Consequently, the mechanical index should not exceed 0.2 except in extremely difficult examinations. The gain should be initially set such that the aorta is just outside of view on contrast imaging. Upon arrival of contrast, the gain should be carefully increased to the highest level possible without creating significant artifact.
Examination is attempted in whichever plane provides the best simultaneous view of the aorta and excluded sac based on B-mode imaging. Initial examination should focus on time of enhancement of the aneurysmal sac vs the endograft lumen. Synchronous enhancement suggests an antegrade leak, whereas delayed enhancement suggests a retrograde leak (type II). Naturally, no sac enhancement suggests against an endoleak.
This examination should continue for at least 10 minutes to ensure that delayed and low-flow endoleaks are identified. If an endoleak is identified, the study should be repeated after disappearance of ultrasound contrast from the circulation, usually within 10 minutes after first injection. Focus should be given to attempting to identify the anatomic source and direction of the endoleak. This should include an examination of the proximal and distal attachment sites, areas of known graft junction, the inferior mesenteric artery, and paired posteriorly oriented lumbar arteries. The key steps of the examination have been outlined in Table 2 .
Challenges in examination typically involve difficulty in adequate visualization of the aorta and related structures. Specifically, in patients with extensive abdominal hernias or significant truncal obesity, transabdominal imaging may be difficult. A coronal approach may be attempted with the patient in a lateral decubitus position. Intervening bowel gas can obstruct distal iliac system visualization. The coronal or flank approach can be used here as well. Although outside the scope of this article, newer state-of-art probes may use high-resolution vascular imaging such as advanced dynamic flow or superb microvascular imaging. 17 These tools may be used with or without contrast and may improve fidelity of low-flow vessels. 17 
ENDOLEAK DETECTION BY CEUS: A TIMELINE IN META-ANALYSES
Early experiences with CEUS suggested sensitivities comparable to CTA in the detection of endoleaks. 18 However, concerns regarding interobserver reliability and inconsistent examination windows remained. 19 Nonetheless, to overcome the limitations of vascular center experiences being published in isolation, several groups have pursued systematic reviews of CEUS for endoleak detection (Table 3) . [8] [9] [10] [11] In one of the earliest large meta-analyses evaluating CEUS in endoleak detection compared with CTA, Mirza et al 8 pooled 7 (of 21 total) studies evaluating CEUS. Using CTA as the criterion standard, they reported a pooled sensitivity of 98% and a pooled specificity of 88%. 8 Of the 288 scan pairs evaluated, only 2 instances of endoleaks were seen on CTA but not CEUS. 8 Contrastingly, 24 endoleaks were appreciated on CEUS and not CTA. 8 They comment that this "high falsepositive rate" may actually suggest an increased sensitivity compared with CTA (the criterion standard) in a particular subset of low-flow endoleaks. 8 Then, in 2012, Karthikesalingam et al 9 pooled 3 additional studies comparing CEUS with CTA and reported a pooled sensitivity of 96% and a pooled specificity of 85%. Interestingly, they performed a secondary analysis using CEUS as the criterion standard instead and reported a CTA pooled sensitivity of only 70% and a pooled specificity of 98%, suggesting that the true sensitivity of CEUS may actually exceed that of CTA. 9 However, they concede a major limitation in that significant variation exists in the CT protocols between patients and studies and that protocol delayed-phase imaging might detect the low-flow endoleaks missed on CTA but seen on CEUS. 9 Similarly, Guo et al 11 pooled 19 studies comparing CEUS and CTA with a total of 1694 paired scans. They note that CEUS found 138 endoleaks that were not identified by CTA, whereas CTA only identified 51 endoleaks not seen on CEUS. 11 However, they do comment that in examination of only type I and type III endoleaks, just 5 endoleaks were detectable on CEUS alone compared with 3 endoleaks on CTA alone, suggesting that many of the endoleaks detected by CEUS alone are type II. 11 More recently, Sun et al 10 pooled 14 studies (of 42) and noted a pooled sensitivity of 88.9% and a pooled specificity of 86.2% (with CTA as the criterion standard). Again, they note that in 11 of their 14 pooled studies, CEUS had a higher rate of endoleak detection than CTA. 10 However, these recent meta-analyses share several common limitations. Notable variability in sonographic technique, CT protocol, and surveillance practice exists. 8 Computed tomographic angiography phase protocols for the evaluation of endoleaks can vary between institutions and practitioners. 20 Venous phase delays as long as 300 seconds may be necessarily performed or added to improve the detection of low-flow endoleaks on CTA. 21 Newer time-resolved CTA imaging adds low-radiation dynamic resolution to otherwise static CT images and may also further facilitate the detection of small or low-flow endoleaks traditionally missed on static-phase CT protocols. 22, 23 In addition, in several of the included studies, the interpreting clinicians were not specifically blinded to the CT findings before performing CEUS. 8 Furthermore, there has been significant evolution in microbubble construct, sonographic hardware, and postprocessing software in the last decade. 11 Taken together, significant interstudy heterogeneity presents an important limitation of all the presented meta-analyses. Moreover, as Guo et al 11 suggest, if many of the unrecognized endoleaks are actually low-flow type II endoleaks for which simply surveillance is advocated, the clinical value in increased sensitivity may be limited.
ENDOLEAK CHARACTERIZATION BY CEUS
The ability to differentiate antegrade endoleaks (types I, III, and IV) from retrograde endoleaks (type II) is critical to management practice. 4 Antegrade endoleaks result from a mechanical failure of sac exclusion by the graft. 4 Contrastingly, retrograde endoleaks pressurize the sac by backward flow from feeding collateral vessels. 4 Although type II endoleaks are frequently observed, type I and all type III endoleaks invariably result in sac expansion and require prompt intervention. 4 Classification provides additional insight into the management of these patients beyond detection. 4 The CEUS may be uniquely positioned for endoleak characterization. Metallic construct is used in various degrees (depending on the endograft) at attachment sites along the body of the graft. These may contribute to metallic streak artifact on CTA, potentially impairing endoleak visualization on arterial phase imaging. 24 Although a similar echo-artifact is a notable limitation of color Doppler ultrasound, this is minimized in CEUS through utilization of low-intensity sonography and postprocessing such as pulse inversion. 25 In addition, because CEUS provides a real-time depiction of blood flow compared with the static angiographic images of CTA, it is possible to determine speed and direction of flow.
11 This is particularly salient when attempting to differentiate antegrade from retrograde endoleaks.
Specifically, CEUS is particularly valuable in the characterization of type II endoleaks. The CEUS has been shown to correctly characterize retrograde endoleaks that were either misclassified or unclassified by CTA. 24, [26] [27] [28] It can identify specific supplying hypertrophic lumbar arteries. 27 Contrastingly, these vessels can be undercharacterized by CTA due to low flow. 16, 27 In relation to the sac, afferent vessels can be differentiated from efferent vessels-or the lack thereof. 28 In addition, wash-in and wash-out kinetics might stratify type II endoleaks by flow dynamics. 28 Low-flow type II endoleaks with traced inflow vessels and without a well-defined outflow may be at higher risk for sac expansion. 16 Taken together, this may have implications in preventing unnecessary angiographic interventions in purported low-risk groups. 24 The detection and categorization of antegrade endoleaks is important because of greater consensus for intervention. Comparable overall detection rates of antegrade endoleaks by CEUS and CTA are described. 9, 11, 27 However, CTA-missed type I and type III endoleaks have both been reported. 16, 19, 24, 29 The CEUS can identify small antegrade endoleaks at both proximal (type Ia) and distal attachment (type Ib) sites that might otherwise be obscured on CTA by graft metallic artifact. 14, 19, 24 Although uncharacterized by CTA, these endoleaks actually necessitated intervention. Investigation into the role of CEUS in type IV (fabric porosity) and type V (endotension or endoleaks of unknown etiology) endoleaks is much more limited. Detection of type IV endoleaks by CEUS has been reported (albeit infrequently, owing to its rarity). 30, 31 Contrastingly, previously classified type V endoleaks may actually be recharacterized after CEUS. 16, 28, 32 Although endotension is still incompletely understood, there is certainly a subset of patients for which the actual origin of sac pressurization (and true endoleak type) is simply poorly demonstrated by CTA. 33 Blackwood et al 32 developed an in vitro model of sac hypertension (simulating endotension) caused by type Ia endoleaks that were only visible on markedly delayed dynamic imaging. Similarly, Millen et al 29 reported a series of 33 patients for which CEUS was used a problem-solving adjunct imaging modality, adding that temporal flow dynamics allowed for further characterization of endoleaks of uncertain or unknown etiology. As noted earlier, slow-or low-flow endoleaks may be particularly problematic for CTA and where CEUS can be diagnostic. 16 Nonetheless, although CEUS seems facile in endoleak classification, CTA is still the preferred modality in assessing actual aneurysmal sac morphology. In addition, structural facets of aortic implants are difficult to reproducibly assess by ultrasound, particularly when evaluating for implant kinking, migration, and anchorage. 8, 16 Although operator dependency certainly plays a role, certain configurations of endoleaks (such as posteriorly oriented type II endoleaks) may also be more difficult to detect on CEUS compared with CTA (owing to the interposed graft). 27 
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CONCLUSIONS
As noted, the early diagnosis and characterization of endoleaks is important in guiding management. Low-risk nonexpanding type II endoleaks are frequently observed. 4 Expanding type II endoleaks may require vessel embolization. 4 Contrastingly, whenever possible, type I and type III endoleaks are repaired through endovascular graft extension, angioplasty, or seal of the component/junction defect. 4 Complex endovascular device deployment (with fenestrations or branches) and surgical approaches exist in patients refractory to standard endovascular interventions. 4 Evidence from large single-center experiences to metaanalyses have been published illustrating the efficacy of CEUS in diagnosing and characterizing endoleaks with rates comparable to (or better than) CTA. However, notable hurdles to CEUS adoption still exist, including technical limitations (hardware and software), operator dependency, and patient-related factors (anatomy and pathology). In addition, CTA still maintains a key role in anatomic and structural characterization of these lesions. However, newer experiences with 4-dimensional CEUS (CEUS with 3-dimensional reconstruction and real-time interrogation) and CEUS-CT fusion techniques are extremely promising and propose an even more robust characterization of in vivo aortic endografts. 34, 35 
